District Court Interprets EKRA
FDA Law Blog
JANUARY 6, 2022
In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. 18 U.S.C. ยง 18 U.S.C. ยง 18 U.S.C. ยง 18 U.S.C. ยง 220(b)(2). EKRA Issue. 18 US.C. ยง
Let's personalize your content